Dr. Hyman B. Muss discusses the unique facets of care that should inform personalized treatment decision-making for older ...

“The emergence of DT-109 as a dual-action drug capable of treating both MASH and the vascular complications associated with ...

Researchers at UCL have tested a new scoring system to measure the risk of stroke in patients with narrowed arteries due to ...

An international research team led by Geneva University Hospital found no increase in cardiovascular events during the first ...

The study confirmed that any increase in Lp (a) levels is directly linked to a higher risk of cardiovascular events such as ...

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

Cholesterol tests check the components of fat in your blood and compare them to normal ranges. Your clinician might also use ...

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back ...

Systemic inflammation and altered lipoprotein profiles are believed to contribute directly to the development of atherosclerosis. Treatment with certain disease-modifying therapies, including TNFi ...